Don't Use Delafloxacin to Treat Most Skin Infections

Delafloxacin (Baxdela, baks-DEH-lah) is a new quinolone antibiotic.

Think of it as similar to levofloxacin, but so far it's only approved to treat skin infections.

And lab data suggest delafloxacin may have better methicillin-resistant Staph aureus (MRSA) coverage than other quinolones.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote